Neoplasia/BPH

	The role of delayed cytoreductive nephrectomy following axitinib-toripalimab for the mRCC patient in current immunotherapy era: a case report and literature review. Front Immunol Zhou Q, Wang J, WenJing M, ZeLin Y, Yan J, Jin X. PMID: 41890724 [PubMed - indexed for MEDLINE]
	Tumor-immune spatiotemporal co-evolution as a paradigm for overcoming therapy resistance in advanced prostate cancer. Front Immunol Xue J, Liao K, Zhang M. PMID: 41890710 [PubMed - indexed for MEDLINE]
	Evaluation of novel treatments for metastatic castration-resistant prostate cancer. Expert Opin Pharmacother Güner G, Arslan C. PMID: 41889024 [PubMed - as supplied by publisher]
	Peripheral monocyte ratio as a predictive biomarker for metastasis-directed therapy in prostate cancer: insights from an exploratory study. BMC Cancer Wang H, Rajagopal A, Cao K, Cimolai K, Petchiny TN, White SD, Cheung J, Loblaw A, Vesprini D, Leong H, Escueta V, Zhang L, Glicksman R, Cheung P, Wang C, Liu SK. PMID: 41888707 [PubMed - as supplied by publisher]
	Clinically significant prostate cancer detection with deep learning in a multi-center magnetic resonance imaging study. Sci Rep Alzate-Grisales JA, Mora-Rubio A, Peán-Teruel M, Beltrán AN, Torres CR, García JMO, García-García F, Tabares-Soto R, García-Gómez JM, de la Iglesia-Vayá M. PMID: 41888535 [PubMed - as supplied by publisher]
	Diagnostic accuracy of PSMA-targeted radioguided surgery in prostate cancer at multiple anatomical levels: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging Wen F, Schäfer L, Zheng X, Huang H, Noordzij W, Saar M, Mottaghy FM, Lütje S. PMID: 41888458 [PubMed - as supplied by publisher]
	Marine fungal-derived natural products against prostate cancer: A comprehensive review of discoveries and mechanisms. Phytochemistry Gao J, Xu S, Zhou X, Liu Y, Wang X, Yang B. PMID: 41887555 [PubMed - as supplied by publisher]
	Editorial Comment on "Patient-Reported Psychological and Prostate Cancer-Specific Functional Outcomes Among Men With Low-Risk Prostate Cancer Two Years After Diagnosis: The PREPARE Prospective Cohort Study". Urology Bradley Mason J, Tallman J. PMID: 41887290 [PubMed - as supplied by publisher]
	Prostate cancer tissue mapping and stratification using DRAQ5 and Eosin fluorescent labels integrated with AI classification and segmentation algorithms. PLoS One Papachristos MG, Spezi E, Fuentes C, Evangelou I, Thomas DH, Akinade F, Wiltshire M, Wilson A, Errington RJ, Parthimos D. PMID: 41886726 [PubMed - indexed for MEDLINE]
	Cost-Effectiveness of Circulating Tumor DNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer Based on IMvigor011 Trial. JCO Oncol Pract Xue Z, Qie Y, Liang S, Li R, Shen C, Wu Z, Chen H, Lin Y, Li P, Hu H. PMID: 41886724 [PubMed - as supplied by publisher]
	Non-metastatic castration-resistant prostate cancer in the epoch of PSMA-ligand PET/CT: twilight? Ann Nucl Med Valsamaki PN, Tsakaldimis G. PMID: 41886175 [PubMed - as supplied by publisher]
	Point-of-Care Detection of Dual Methylation Genes for Rapid Bladder Cancer Diagnosis and Prognosis. Anal Chem Qiao S, Li Y, Gao Y, Li K, Qi R, Han D, Zhang C. PMID: 41885754 [PubMed - as supplied by publisher]
	Consolidation enfortumab vedotin and pembrolizumab after cisplatin induction in metastatic urothelial cancer: Outcomes of complete response and bladder preservation. J Int Med Res Chan KH, Cen P, Shu T, Canfield S, Zhao H, Gonzalez A, Rowe J, Tammisetti V, Ayoub H, Blanco A, Amsbaugh M, Tannir N. PMID: 41885091 [PubMed - indexed for MEDLINE]
	Radical cystectomy practice patterns in the Nordic countries: results from the prospective NorCys study. Scand J Urol Venhomaa T, Nikulainen I, Bobjer J, Bläckberg M, Bro L, Brandt SB, Ettala O, Fabrin K, Gudjonsson S, Haug ES, Högerman M, Hyldgaard JM, Jerlström T, Kirrander P, Koskinen I, Lam G, Leskinen MJ, Liedberg F, Livbjerg AH, Seikkula H, Skovhus K, Ströck V, Tuckus G, Virta V, Vrang ML, Jensen JB, Boström PJ. PMID: 41884949 [PubMed - indexed for MEDLINE]
	Review of the effect of atrazine on the HPG axes and steroidogenic pathways in males: relevance for testicular and prostate cancer. Front Toxicol Cooper RL, Simpkins JW, Breckenridge C. PMID: 41884656 [PubMed]
	Evaluation of efficacy in prostate cancer contouring for MR-guided radiotherapy using structured contouring training modules. Tech Innov Patient Support Radiat Oncol Fang B, Zahary Loreman H, Bayley C, Stewart C, George K, Al-Amoodi M, Jooya A, Quon H, Sia M, Lee SL. PMID: 41884629 [PubMed]
	Synergy of PET and MR imaging in the local and regional staging of bladder cancer. Ther Adv Urol Xu MC, Sandberg ML, Childs DD, Cengiz TB, Walker CH, Rais-Bahrami S. PMID: 41884183 [PubMed]
	Prognostic and clinicopathological value of the prognostic nutritional index in prostate cancer treated with androgen deprivation therapy: a systematic review and meta-analysis. Front Oncol Huang H, Hu J, Lan X, Li H, Chen J. PMID: 41883977 [PubMed]
	Actinium-225-PSMA versus lutetium-177-PSMA radioligand therapy for metastatic castration-resistant prostate cancer: results of an observational study. Front Oncol Kochetova TY, Potievskiy MB, Nekrasova LA, Krylov VV, Shegai PV, Ivanov SA, Kaprin AD. PMID: 41883973 [PubMed]
	PSMA PET-guided intensification of postprostatectomy salvage radiotherapy for prostate cancer: a systematic review and meta-analysis. Front Oncol Liu G, Shu Y, Hong J, Li Z, Yang X. PMID: 41883961 [PubMed]

Articles 1 - 20 / 186602

Page 1 of 9331



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy